<bill session="112" type="s" number="2301" updated="2020-02-10T17:00:01Z">
  <state datetime="2012-04-19">REFERRED</state>
  <status>
    <introduced datetime="2012-04-19"/>
  </status>
  <introduced datetime="2012-04-19"/>
  <titles>
    <title type="short" as="introduced">Tanning Transparency and Notification Act of 2012</title>
    <title type="display">Tanning Transparency and Notification Act of 2012</title>
    <title type="official" as="introduced">A bill to help prevent the occurrence of cancer resulting from the use of ultraviolet tanning lamps by providing sufficient information to consumers regarding the health risks associated with the use of such devices.</title>
  </titles>
  <sponsor bioguide_id="R000122"/>
  <cosponsors>
    <cosponsor bioguide_id="I000055" joined="2012-04-19"/>
  </cosponsors>
  <actions>
    <action datetime="2012-04-19">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2012-04-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S2547-2548"/>
    </action>
    <action datetime="2012-04-19" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Cancer"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government studies and investigations"/>
    <term name="Musculoskeletal and skin diseases"/>
    <term name="Product safety and quality"/>
  </subjects>
  <amendments/>
  <summary date="2012-05-18T17:43:11Z" status="Introduced in Senate">Tanning Transparency and Notification Act of 2012 - Directs the Commissioner of Food and Drugs (FDA) to carry out the recommendations made in the report submitted under the Food and Drug Administration Amendments Act of 2007 regarding the labeling of indoor tanning devices to provide information to consumers about the health risks posed by such devices.</summary>
</bill>
